Surgical castration in hormone-refractory metastatic prostate cancer patients can be an alternative for medical castration

Advances in Urology

Volumn , Issue , 2012, Pages

  Takeuchi, Takumi ^a   Zaitsu, Masayoshi ^a   Yamanoi, Mariko ^a   Mikami, Koji ^a   Takeshima, Yuta ^a   Okamoto, Naohiko ^a   Imao, Sadao ^a   Tonooka, Akiko ^a  

^a KANTO ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052673600     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2012/979154     Document Type: Article

References (13)

1. White J. W., I. The results of double castration in hypertrophy of the prostate Annals of Surgery 1895 22 1 1 80
2. Huggins C., Hodges C. V., Studies on prostate cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate Cancer Research 1941 1 1 293 297
3. Wenderoth U. K., Happ J., Krause U., Adenauer H., Jacobi G. H., Endocrine studies with a gonadotropin-releasing hormone analogue to achieve withdrawal of testosterone in prostate carcinoma patients European Urology 1982 8 6 343 347 (Pubitemid 13253333)
4. Curry E. A. III, Sweeney C. J., Resistance to luteinizing hormone releasing hormone agonist therapy for metastatic prostate cancer Journal of Urology 2002 168 1 193 (Pubitemid 34640819)
5. Krongrad A., Brady J., Rodriguez R. J., Resistance to gonadotropin-releasing hormone agonist in a patient with metastatic prostate cancer Southern Medical Journal 1997 90 4 460 461 (Pubitemid 27176419)
6. Oefelein M. G., Cornum R., Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: the case for monitoring serum testosterone and a treatment decision algorithm Journal of Urology 2000 164 3 726 729 (Pubitemid 30637611)
7. Novara G., Galfano A., Secco S., Ficarra V., Artibani W., Impact of surgical and medical castration on serum testosterone level in prostate cancer patients Urologia Internationalis 2009 82 3 249 255
8. Oefelein M. G., Feng A., Scolieri M. J., Ricchiutti D., Resnick M. I., Reassessment of the definition of castrate levels of testosterone: implications for clinical decision making Urology 2000 56 6 1021 1024
9. Olapade-Olaopa E. O., Oluwasola A. O., Shonibare A., Falebita O. A., Akang E. E., Shokunbi M. T., Bilateral orchidectomy in three metastatic prostate cancer patients with failed LHRH-agonist therapy South African Medical Journal 2006 96 9 810 811 (Pubitemid 44463063)
10. Valle L. D., Belvederea P., Simontacchia C., Colombo L., Extraglandular hormonal steroidogenesis in aged rats Journal of Steroid Biochemistry and Molecular Biology 1992 43 8 1095 1098 (Pubitemid 23044725)
11. Sievers C., Klotsche J., Pieper L., Schneider H. J., Mrz W., Wittchen H. U., Stalla G. K., Mantzoros C., Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients European Journal of Endocrinology 2010 163 4 699 708
12. Mostaghel E. A., Page S. T., Lin D. W., Fazli L., Coleman I. M., True L. D., Knudsen B., Hess D. L., Nelson C. C., Matsumoto A. M., Bremner W. J., Gleave M. E., Nelson P. S., Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer Cancer Research 2007 67 10 5033 5041 (Pubitemid 46910214)
13. Denmeade S. R., Isaacs J. T., Bipolar androgen therapy: the rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancer Prostate 2010 70 14 1600 1607